Dark | Light
# ![@DCVaxDefender Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1772690455387316225.png) @DCVaxDefender autologous assassin πŸ‡ΊπŸ‡ΈπŸ‡¨πŸ‡±βšœοΈπŸ΄β€β˜ οΈ

autologous assassin πŸ‡ΊπŸ‡ΈπŸ‡¨πŸ‡±βšœοΈπŸ΄β€β˜ οΈ posts on X about $nwbo, $ibrx, if you, in the the most. They currently have [---] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::1772690455387316225/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1772690455387316225/c:line/m:interactions.svg)

- [--] Week [-----] +198%
- [--] Month [------] +260%
- [--] Months [-------] +34%

### Mentions: [--] [#](/creator/twitter::1772690455387316225/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1772690455387316225/c:line/m:posts_active.svg)

- [--] Week [--] -10%
- [--] Month [--] +80%
- [--] Months [---] +38%

### Followers: [---] [#](/creator/twitter::1772690455387316225/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1772690455387316225/c:line/m:followers.svg)

- [--] Week [---] +0.94%
- [--] Month [---] +1.40%
- [--] Months [---] +21%

### CreatorRank: [-------] [#](/creator/twitter::1772690455387316225/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1772690455387316225/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  28% [stocks](/list/stocks)  9% [travel destinations](/list/travel-destinations)  6% [technology brands](/list/technology-brands)  3% [countries](/list/countries)  2% [fashion brands](/list/fashion-brands)  1% [luxury brands](/list/luxury-brands)  1% [cryptocurrencies](/list/cryptocurrencies)  1% [exchanges](/list/exchanges)  1% [automotive brands](/list/automotive-brands)  1%

**Social topic influence**
[$nwbo](/topic/$nwbo) #4, [$ibrx](/topic/$ibrx) 23%, [if you](/topic/if-you) 5%, [in the](/topic/in-the) 5%, [approval](/topic/approval) #167, [we are](/topic/we-are) 4%, [liquidity](/topic/liquidity) 4%, [london](/topic/london) 4%, [st louis](/topic/st-louis) 4%, [the world](/topic/the-world) 3%

**Top accounts mentioned or mentioned by**
[@andrewcaravello](/creator/undefined) [@grok](/creator/undefined) [@bambossie81](/creator/undefined) [@elvirpons](/creator/undefined) [@kryptypop](/creator/undefined) [@atlnsider](/creator/undefined) [@jacobyorkndxt](/creator/undefined) [@dwpamont](/creator/undefined) [@smith348572](/creator/undefined) [@chriscuomo](/creator/undefined) [@tonyverazzanno](/creator/undefined) [@flemmingbruce](/creator/undefined) [@dstock07734](/creator/undefined) [@urbancourtyard](/creator/undefined) [@clausknielsen](/creator/undefined) [@thealepalombo](/creator/undefined) [@jtsla4](/creator/undefined) [@thomasowenmcca1](/creator/undefined) [@albturmnymkrs](/creator/undefined) [@stonkmasterj](/creator/undefined)

**Top assets mentioned**
[ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Palantir Technologies Inc. (PLTR)](/topic/$pltr) [HCA Healthcare Inc (HCA)](/topic/$hca) [Booz Allen Hamilton Holding, Corp. (BAH)](/topic/$bah)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Airports are monuments to American failure in transportation planning. We force [------] mile trips onto the most carbon-intensive least resilient mode then celebrate bigger terminals while Europe rides electrified rail through heat waves with their dogs and dignity intact. Security theater hub fragility weather cascades massive CO thus this is not "progress." Its systems malpractice. Let's not memory-hole this: Carl Icahn strip-mined TWA hollowed out St. Louis as a global hub and walked away richer while an entire regional air network collapsed. That's the airline model of financial extraction"  
[X Link](https://x.com/DCVaxDefender/status/2017279967332040816)  2026-01-30T16:53Z [---] followers, [----] engagements


"Calling property tax a tax on unrealized gains is economically illiterate. Full stop. Property tax is not a wealth tax not a capital-gains tax and not some sneaky Zillow hallucination. It is a land-use and service-recovery tax on immobile assets that continuously consume public infrastructure. If you dont understand that distinction you shouldnt be opining on tax policy [--]. Property value paper wealth Your homes assessed value is not a random spreadsheet number. It reflects real cumulative public investment: [--] Roads and resurfacing 2.Water sewer and stormwater systems that last [-----] years"  
[X Link](https://x.com/DCVaxDefender/status/2017288653064581618)  2026-01-30T17:27Z [---] followers, [----] engagements


"@albtur_mnymkrs @StonkMasterJ King's College isn't a commercial GMP covered under $NWBO MIA. Management would not allocate opex on this hire if no revenue coming soon. Her credentials are from Kings College and HCA Healthcare which is one of the largest private hospital systems in the world. Qualified"  
[X Link](https://x.com/DCVaxDefender/status/2020954450496454996)  2026-02-09T20:14Z [---] followers, [---] engagements


"As an American living in Texas (no state income tax) the math is very different for me. I am happy to buy property in Italy and spend money supporting wineries restaurants artisans but I am not becoming an Italian tax resident or moving my IRA into a foreign tax system. Under Schengen rules I can visit up to [--] days in any 180-day period without triggering residency. That's more than enough for a seasonal base. No need to overcomplicate it. I analyzed every coastal town in Italy on a 1M budget. Taxes. Airports. What 1M actually buys you in each location. I cross-checked every detail with two"  
[X Link](https://x.com/DCVaxDefender/status/2021701471717199904)  2026-02-11T21:42Z [---] followers, [--] engagements


"@EWErickson Most Americans do not have a 401K or enough savings to retire. Appealing to the top 1% does not work as we are also for locking up pedophiles"  
[X Link](https://x.com/DCVaxDefender/status/2021746681407250697)  2026-02-12T00:42Z [---] followers, [---] engagements


"@fendyluck Do you know what it means to miss New Orleans https://youtu.be/m4jU8IQK5b0si=r7Jg0TVJyST2lsv2 https://youtu.be/m4jU8IQK5b0si=r7Jg0TVJyST2lsv2"  
[X Link](https://x.com/DCVaxDefender/status/2022490074336891150)  2026-02-14T01:56Z [---] followers, [---] engagements


"What's the hold up for $NWBO Honestly we do not know as there's no comparable baseline. DCVax-L had [--] CHM meetings [--] months apart. No other MHRA approval has followed that path. N=1 means not enough data to do any comparative analysis. What we do know: 1) Data is unambiguously excellent (HR 0.80/0.58 p0.002/0.001) 2) Better stats than Optune which FDA approved YESTERDAY 3) SAP pre-specified before data lock so no data dredging 4) Manufacturing already approved 5) No rejection language from MHRA 6) Company burning additional capex (Flaskworks Class C) and opex (patient hire & Pittsburgh"  
[X Link](https://x.com/DCVaxDefender/status/2022358288663495036)  2026-02-13T17:12Z [---] followers, [----] engagements


"@DWpaMont Then I guess it's @UofIllinois for $NWBO shareholders"  
[X Link](https://x.com/DCVaxDefender/status/2022515054852362555)  2026-02-14T03:35Z [---] followers, [---] engagements


"You cannot ethically randomize dying patients to placebo. That's why every UK-approved CAR-T got approved on single-arm trials with no control group. GBM patients face the same reality which $NWBO DCVax-L trial proved as 90% crossed over because they refused to die on placebo. For context UK-approved CAR-Ts with NO control group: - Kymriah - Yescarta - Tecartus - Breyanzi - Abecma - Carvykti - Aucatzyl After MHRA approved Aucatzyl (an autologous not allogeneic CAR-T) NICE approved it for NHS reimbursement. This all happened only a few months apart in [----]. Aucatzyl had: - Single-arm trial -"  
[X Link](https://x.com/DCVaxDefender/status/2022716621475795153)  2026-02-14T16:56Z [---] followers, [---] engagements


"I need to get the Pol Roger ready for $NWBO approval"  
[X Link](https://x.com/DCVaxDefender/status/2020956261467160866)  2026-02-09T20:21Z [---] followers, [----] engagements


"Management has stated several times they are going to market with the approved open system manufacturing process which MHRA approved in [----]. This requires Class B (ISO [--] at rest) which $NWBO built in Sawston at great expense. The Class C cleanrooms (ISO [--] at rest) and Flaskworks bridging study is not delaying DCVax MAA. If ISO [--] manufacturing was gating approval that's material and would be disclosed in SEC filings with the many other risks outlined. In fact management said in PR that the approved MIA license was a prerequisite for MAA approval. The same has never been said about Flaskworks"  
[X Link](https://x.com/DCVaxDefender/status/2022391683950752082)  2026-02-13T19:25Z [---] followers, [---] engagements


"@grok Market makers respond to order flow. If there's no liquidity in the $NWBO UK listing there's nothing to hedge nothing to absorb nothing to "manipulate." Price discovery happens where: - Volume is highest - Spreads are tightest - Institutions transact For Northwest Biotherapeutics that's the US OTC market not a thin UK side listing. If meaningful buying showed up in the UK arbitrage desks would immediately connect it to the US market and close any pricing gap. If there's no volume there's no signal no pressure no structural effect. No liquidity = no mechanism"  
[X Link](https://x.com/DCVaxDefender/status/2023083525117718937)  2026-02-15T17:14Z [---] followers, [--] engagements


"The market infrastructure in London and Stuttgart is real. It has aspects which are far superior to OTCQB. Yet the implication that it overrides lack of $NWBO European liquidity is not. Auctions settlement rules and takeover-code tweaks do not create demand rather they just process it. Without sustained European volume US OTC remains the price discovery venue. Order flow moves the price not market plumbing. https://twitter.com/i/web/status/2023086909606510631 https://twitter.com/i/web/status/2023086909606510631"  
[X Link](https://x.com/DCVaxDefender/status/2023086909606510631)  2026-02-15T17:28Z [---] followers, [--] engagements


"Reminder for fellow $NWBO shareholders: In [----] Parliament asked MHRA multple times what's going on with the DCVax approval process The answer was under evaluation. No signal of failure. No rejection language. In addition MHRA already approved DCVax manufacturing. DCVax trial was highly statistically significant. No systemic safety issues. Terminal orphan indication. If there were a fatal problem MHRA would not be saying under review to Parliament instead they would be signaling additional requirements. We would have heard about fatal issues long ago. They do not suddenly manifest after two"  
[X Link](https://x.com/DCVaxDefender/status/2022155193928810971)  2026-02-13T03:45Z [---] followers, [----] engagements


"Shorts reacting to $NWBO approval"  
[X Link](https://x.com/DCVaxDefender/status/2022834998294851721)  2026-02-15T00:47Z [---] followers, [---] engagements


"For anyone unfamiliar arbitrage is when traders buy a stock in one market and simultaneously sell it in another to capture a price difference. If $NWBO were truly trading at $1.78 in London while its $0.24 in the US professionals would close that gap immediately. Persistent 600% spreads NEVER exist in functioning markets because capital eliminates them immediately. Before repeating structural claims online it's worth understanding how cross-market pricing actually works. https://twitter.com/i/web/status/2023084505079165135 https://twitter.com/i/web/status/2023084505079165135"  
[X Link](https://x.com/DCVaxDefender/status/2023084505079165135)  2026-02-15T17:18Z [---] followers, [--] engagements


"$IBRX pumping NK/IL-15 as a GBM breakthrough completely ignores basic tumor biology. Expanding NK cells solving glioblastoma. It also ignores the approach that works which $NWBO proved in PIII peer review published in JAMA. GBM is one of the most heterogeneous infiltrative tumors in human biology. Tumor cells are constantly changing and invading normal brain tissue. You do not fix that with a generic cytokine bath rather you need patient-specific antigen presentation and real T-cell priming. On top of that GBM actively suppresses NK pathways: HLA-E/HLA-G expression and TGF- in the tumor"  
[X Link](https://x.com/DCVaxDefender/status/1994585558920626572)  2025-11-29T01:53Z [---] followers, [---] engagements


"@jersey_ham So sorry to hear that David 😒"  
[X Link](https://x.com/DCVaxDefender/status/1994628653033103409)  2025-11-29T04:45Z [---] followers, [---] engagements


"Yeah it is wild because the entire IL-15 / $IBRX premise collapses the moment you apply basic tumor immunology and compare it to what $NWBO is actually doing. IL-15 expands NK cells and expands already-existing effector/memory CD8 T-cells and some memory/activated CD4 helper T-cells. It cannot create new tumor-specific cytotoxic T-cells because only dendritic cells can prime nave T-cells with the tumors full antigenic blueprint. In GBM (and most metastatic heterogeneous cancers): [--]. Dendritic cells are suppressed and depleted [--]. CD4 helpers are dysfunctional and unprimed [--]. CD8 cytotoxic"  
[X Link](https://x.com/DCVaxDefender/status/1994644461876371585)  2025-11-29T05:47Z [---] followers, [----] engagements


"Throwing [---] octane gasoline into a blown engine will not win the Daytona [---]. @andrewcaravello correct about $IBRX which does not target tumor antigens. It will not work for Glioblastoma or any metastatic cancer indication. $NWBO has proven results. https://x.com/DCVaxDefender/status/1994644461876371585t=0bz5gV4CuAt4a3SohUPyfA&s=19 https://x.com/DCVaxDefender/status/1994644461876371585t=0bz5gV4CuAt4a3SohUPyfA&s=19 @smith348572 @weldeiry @AlMusella @DrPatSoonShiong @ChrisCuomo @WIN_Consortium @MHRAgovuk Yeah it is wild because the entire IL-15 / $IBRX premise collapses the moment you apply"  
[X Link](https://x.com/DCVaxDefender/status/1994813211908931816)  2025-11-29T16:58Z [---] followers, [----] engagements


"@BAMBossie81 Keep trolling $NWBO. We are immune unlike patients getting IL-15 1B $IBRX shares + cytokine that does nothing for metastatic indications. Another $CVM πŸ“‰πŸ“‰πŸ“‰πŸ“‰ πŸ˜†πŸ˜†πŸ˜†πŸ˜† https://x.com/DCVaxDefender/status/1994813211908931816t=qL6vsOsJ_K6Gjmg1NZzTAw&s=19 @BAMBossie81 Throwing [---] octane gasoline into a blown engine will not win the Daytona [---]. @andrewcaravello correct about $IBRX which does not target tumor antigens. It will not work for Glioblastoma or any metastatic cancer indication. $NWBO has proven results. https://t.co/v0rDWRxMuu https://t.co/1JHBNtYJdf"  
[X Link](https://x.com/DCVaxDefender/status/1994847109145919767)  2025-11-29T19:13Z [---] followers, [----] engagements


"1/2 Your response comparing $IBRX to $NWBO contains a great deal of technical decoration but none of it addresses the single scientific question that determines whether a cancer immunotherapy has any chance of working. How does the platform generate new tumour specific T cell clones. If a treatment cannot create new cytotoxic T cells that recognise the patients own tumour antigens then it cannot produce lasting control of any metastatic cancer. Nothing in your explanation shows that this is happening with the Bioshield system. The core scientific defect remains untouched. Cancer disables"  
[X Link](https://x.com/DCVaxDefender/status/1994863392817823845)  2025-11-29T20:17Z [---] followers, [---] engagements


"2/2 $NWBO $IBRX You also do not address the lack of any overall survival evidence for Anktiva or for the larger Bioshield concept. There is no validation that any of the described circuitry produces a survival benefit in any metastatic indication. The pivotal study for Anktiva lacked a randomised control arm lacked a p value for survival lacked a comparison to Bacillus Calmette Guerin alone and was subsequently refused for filing by the FDA for other subtypes. There is no evidence that the approach has altered the natural history of any solid tumour. By contrast dendritic cell therapy has"  
[X Link](https://x.com/DCVaxDefender/status/1994863842141020584)  2025-11-29T20:19Z [---] followers, [---] engagements


"The immune system army is blind exhausted lost and untrained so let's just give them cocaine and hope something good happens. That is literally the $IBRX BioShield model"  
[X Link](https://x.com/DCVaxDefender/status/1994866744746557527)  2025-11-29T20:31Z [---] followers, [---] engagements


"@andrewcaravello @BillMur81205942 @MK2forU Multikine and Rindopepimut looked promising then failed in Phase III trials. Metastatic tumors evolve so you must monitor populations over time. If $IBRX investors do not understand basic concepts then they should not be investing in the extremely risky biotechnology sector"  
[X Link](https://x.com/DCVaxDefender/status/1994883690426486997)  2025-11-29T21:38Z [---] followers, [--] engagements


"$IBRX $NWBO Bad biology is the enemy. There is no "unity" between a treatment that cannot succeed in solid tumours and a platform that was specifically built to solve the immunologic collapse that solid tumours create. Anktiva plus BCG is a bladder regimen where BCG does the work. DCVax is an antigen-instruction platform with Overall Survival data in an immunosuppressive cold solid tumour. These technologies are not comparable and they do not support each other. One amplifies dysfunction whereas the other corrects it. One has zero population data in any solid metastatic tumour and the other"  
[X Link](https://x.com/DCVaxDefender/status/1994933716737544542)  2025-11-30T00:57Z [---] followers, [---] engagements


"$IBRX $NWBO What Dr. Soon-Shiong said on NewsNation deserves a calm scientific correction because the claims being circulated online are not supported by oncology immunology or pathology. They are alarming but not accurate. [--]. "Spike protein inside tumors" is not a documented phenomenon. There is no peer-reviewed evidence showing spike protein accumulating in tumors driving tumor biology or altering oncogenic pathways. If such a finding existed it would have been published immediately by major academic centers. It has not been observed by pathologists tumour boards or molecular labs. The"  
[X Link](https://x.com/DCVaxDefender/status/1995173668935065926)  2025-11-30T16:50Z [---] followers, 11.8K engagements


"@cjp1816 Fidelity are #1 choice for employer-funded retirement accounts By design they restrict customers from making their own decisions. Move to Schwab which allows $NWBO orders well above current bid ask. These ladder sells force buyers to meet us at our desired price. πŸ’£πŸš€πŸ“ˆπŸ‘©πŸš€πŸŒ›"  
[X Link](https://x.com/DCVaxDefender/status/1995548168436466072)  2025-12-01T17:38Z [---] followers, [---] engagements


"@BAMBossie81 @KryptyPop @grok How does $IBRX get to 1B shares without dilution"  
[X Link](https://x.com/DCVaxDefender/status/1995565444418470076)  2025-12-01T18:47Z [---] followers, [---] engagements


"@BAMBossie81 @KryptyPop @grok I worked at one of the top research hospitals in the world. Keep shilling $IBRX for a billionaire simp"  
[X Link](https://x.com/DCVaxDefender/status/1995569243610566726)  2025-12-01T19:02Z [---] followers, [---] engagements


"@BAMBossie81 @KryptyPop @grok $IBRX $NWBO https://x.com/DCVaxDefender/status/1994813211908931816t=fxZCz0zUT35P0xMfDlNkZQ&s=19 @BAMBossie81 Throwing [---] octane gasoline into a blown engine will not win the Daytona [---]. @andrewcaravello correct about $IBRX which does not target tumor antigens. It will not work for Glioblastoma or any metastatic cancer indication. $NWBO has proven results. https://t.co/v0rDWRxMuu https://t.co/1JHBNtYJdf https://x.com/DCVaxDefender/status/1994813211908931816t=fxZCz0zUT35P0xMfDlNkZQ&s=19 @BAMBossie81 Throwing [---] octane gasoline into a blown engine will not win"  
[X Link](https://x.com/DCVaxDefender/status/1995573085068820643)  2025-12-01T19:17Z [---] followers, [---] engagements


"@ATLnsider Do you think there could be merit to $NWBO including [--] year survival data in their NICE evidence submission This would provide them additional QALYs"  
[X Link](https://x.com/DCVaxDefender/status/1995591049302213073)  2025-12-01T20:29Z [---] followers, [---] engagements


"@Investisco Congratulations I am now at 814K shares"  
[X Link](https://x.com/DCVaxDefender/status/1995603410910150996)  2025-12-01T21:18Z [---] followers, [---] engagements


"🚨 REALITY CHECK: $IBRX got REFUSED TO FILE by FDA for papillary NMIBC. 🚨 Same study FDA "approved" before Now insufficient for regulatory review. Translation: The treatment does not work. Soon-Shiong blaming FDA = classic scam playbook. No real efficacy in the population (Cohort C) that matters. Just a billionaire pumping vaporware. Meanwhile $NWBO has Phase III JAMA-published survival data in GBM with 10+ year survivors. IL-15 expands dysfunctional cells. DCVax rebuilds immune intelligence. One has evidence. One has a Refusal to File. Stop buying the hype. You will lose your money"  
[X Link](https://x.com/DCVaxDefender/status/1995607348996395370)  2025-12-01T21:34Z [---] followers, [----] engagements


"🚨 $IBRX's PR Response Shows Classic Red Flags: "FDA gave us unanimous guidance in January" "We're shocked by this inconsistent response" "Former FDA official says it's incomprehensible" REALITY CHECK: If Cohort B data were adequate FDA would have filed it. RTF = fundamental deficiencies in the application. FDA approved CIS+papillary (Cohort A) for a small high-risk population with limited options. But papillary-ONLY (Cohort B) which represents 90% of NMIBC patients REFUSED TO FILE. The implication: IL-15 may not work without the CIS component driving the immune response. Why this matters:"  
[X Link](https://x.com/DCVaxDefender/status/1995610460842787324)  2025-12-01T21:46Z [---] followers, [---] engagements


"1/2 $XBI $NWBO 🚨 A Complete Timeline of $IBRX Regulatory Failures 🧡 ImmunityBio claims to be developing treatments for glioblastoma and other cancers. Here's what investors need to know about their actual track record with regulators: MAY 2023: Complete Response Letter (CRL) FDA rejects BLA due to MANUFACTURING DEFICIENCIES at third-party contract manufacturers Not clinical data issues as they could not meet basic GMP standards. Stock crashes 50% overnight ($6.22 $3.39) Source: Fierce Pharma May [--] [----] OCTOBER 2023: BLA Resubmission Company addresses manufacturing issues FDA accepts"  
[X Link](https://x.com/DCVaxDefender/status/1995616728332509382)  2025-12-01T22:11Z [---] followers, [----] engagements


"2/2 $XBI $NWBO $IBRX The Scientific Problem: IL-15 is an innate immune cytokine that expands NK cells and existing T dysfunctional cells. IBRX CANNOT: πŸ“‰Create new tumor-specific T cell responses πŸ“‰Provide antigen recognition for heterogeneous tumors πŸ“‰Build durable adaptive immunity without proper DC priming The Cohort A approval (CIS patients) likely succeeds because CIS creates local inflammation that provides some antigenic stimulation. Remove that (Cohort B = papillary-only) and the mechanism falls apart. GLIOBLASTOMA CLAIMS: ImmunityBio promotes ongoing GBM research. What $IBRX has in"  
[X Link](https://x.com/DCVaxDefender/status/1995619620087124026)  2025-12-01T22:22Z [---] followers, [----] engagements


"@JacobYorkndxt $IBRX does not create immune memory. Mouse studies mean nothing for Glioblastoma. This is damaging to patients and investors"  
[X Link](https://x.com/DCVaxDefender/status/1995628786013061411)  2025-12-01T22:59Z [---] followers, [---] engagements


"@truedat999 Keep pumping mouse studies $IBRX https://x.com/DCVaxDefender/status/1995628786013061411t=6Xf4gHtkZovzj8w7a7359w&s=19 @JacobYorkndxt $IBRX does not create immune memory. Mouse studies mean nothing for Glioblastoma. This is damaging to patients and investors. https://t.co/Msi1EOpfNv https://x.com/DCVaxDefender/status/1995628786013061411t=6Xf4gHtkZovzj8w7a7359w&s=19 @JacobYorkndxt $IBRX does not create immune memory. Mouse studies mean nothing for Glioblastoma. This is damaging to patients and investors. https://t.co/Msi1EOpfNv"  
[X Link](https://x.com/DCVaxDefender/status/1995663448391536874)  2025-12-02T01:16Z [---] followers, [---] engagements


"@TonyVerazzanno You are not voting yes to add [---] million $NWBO shares. You are voting yes to amend the Articles of Incorporation to make 2.6B the maximum amount authorized. We have 100M authorized Class C shares and less than 1% have been sold. It's either amend Articles or Reverse Split"  
[X Link](https://x.com/DCVaxDefender/status/1995925421649735918)  2025-12-02T18:37Z [---] followers, [---] engagements


"@JacobYorkndxt Talking to @ChrisCuomo isn't a viable business plan for $IBRX"  
[X Link](https://x.com/DCVaxDefender/status/1995927094036234292)  2025-12-02T18:44Z [---] followers, [---] engagements


"@FlemmingBruce 😭 $IBRX 😭"  
[X Link](https://x.com/DCVaxDefender/status/1995928208362127638)  2025-12-02T18:49Z [---] followers, [---] engagements


"@TommyBaxendale @TonyVerazzanno @IrishMc67 To be clear "already over" does not mean anything was done incorrectly. Derivatives are never included in outstanding share counts. If anyone's to blame for this situation it's market makers swing traders and shorts which keep share price depressed. Not management's fault"  
[X Link](https://x.com/DCVaxDefender/status/1995986048220901599)  2025-12-02T22:38Z [---] followers, [--] engagements


"@peter_mantas And do what He picked these mfers"  
[X Link](https://x.com/DCVaxDefender/status/1996023134621667673)  2025-12-03T01:06Z [---] followers, [--] engagements


"$NWBO https://youtu.be/9_DSE3FSalMsi=Acq5aWI2HyMu-SEL https://youtu.be/9_DSE3FSalMsi=Acq5aWI2HyMu-SEL"  
[X Link](https://x.com/DCVaxDefender/status/1996086624824754340)  2025-12-03T05:18Z [---] followers, [---] engagements


"Survey says: [--] out of [--] $XBI investors who got a D+ biology prefer $IBRX over $NWBO and $MRK @andrewcaravello https://t.co/ycD0LrGamx @andrewcaravello https://t.co/ycD0LrGamx"  
[X Link](https://x.com/DCVaxDefender/status/1996617927223816298)  2025-12-04T16:29Z [---] followers, [----] engagements


"@siixandserello @SnackBioTech @FlemmingBruce @adamfeuerstein Unstoppable powerhouses do not get Complete Response Letters and Refusals to File from the FDA. $IBRX have been in a downward spiral since FDA found they couldn't even manufacture an off the shelf cytokine properly. Sued by shareholders. Lost. https://news.bloomberglaw.com/litigation/immunitybio-10-5-million-settlement-over-record-selloff-gets-ok https://news.bloomberglaw.com/litigation/immunitybio-10-5-million-settlement-over-record-selloff-gets-ok"  
[X Link](https://x.com/DCVaxDefender/status/1996748617420296502)  2025-12-05T01:09Z [---] followers, [---] engagements


"@TheSadvocate @TurdFNOLA5 They pay taxes every time they go to Home Depot"  
[X Link](https://x.com/DCVaxDefender/status/1996984178915582091)  2025-12-05T16:45Z [---] followers, [---] engagements


"$PLTR at a [---] P/E and [---] forward P/E straight comedy $430B market cap built on Alex Karp doing a full Tom-Cruise-on-coke routine while the company prints pennies per share. Meanwhile $NWBO DCVax is sitting on a platform that rewrites oncology extends survival in glioblastoma (something no Big Pharma has cracked in [--] years) runs fully automated manufacturing and plugs directly into the future of individualized medicine across every solid tumor. One is hype riding a fragile narrative. The other is a first-in-class regulator-aligned IP-fortified therapeutic with real clinical outcomes and"  
[X Link](https://x.com/DCVaxDefender/status/1998049944280654294)  2025-12-08T15:20Z [---] followers, [----] engagements


"Booz Allen $BAH earns $6.54/share runs cyber + intel for the US government has [--] years of mission-critical contracts and trades at a [--] PE with a $10.7B market cap. Palantir $PLTR earns $0.24/share sells dashboards + AI buzzwords and trades at a [---] PE with a $430B market cap because the CEO does a Twitch-streamer-on-cocaine routine. If the market is willing to give THAT a $400B valuation dont tell me NWBOs first-in-class clinically validated regulator-aligned immunotherapy platform is not worth tens of billions. The whole market is upside down"  
[X Link](https://x.com/DCVaxDefender/status/1998052761347244436)  2025-12-08T15:31Z [---] followers, [---] engagements


"Diversification is protection against ignorance. If you know what you are doing then it makes little sense"  
[X Link](https://x.com/DCVaxDefender/status/1998202382917014016)  2025-12-09T01:25Z [---] followers, [---] engagements


"We should NOT be asking $NWBO management or George to "reach out" to YouTubers meme-stock personalities or anyone sitting on the "Genius Board." NWBO is a clinical-stage biotech on the verge of real approvals real revenue and real global partnerships. This is not GME AMC or any other retail-driven circus. Management's focus needs to stay exactly where it is: regulators manufacturing scale-up reimbursement and strategic negotiations not chasing influencers on social media. Let's keep this community serious and aligned with the scale of what's coming. NWBO isn't a meme stock. It's a future"  
[X Link](https://x.com/DCVaxDefender/status/1998414525108822209)  2025-12-09T15:28Z [---] followers, [---] engagements


"@ElvirPons @DerrickEvans4WV Health savings accounts are not an alternative to health insurance. Simply a tax haven. If you have no income (poor) you already pay little to no tax. GOP does not want government spending or regulations on health because they think healthcare is a private responsibility"  
[X Link](https://x.com/DCVaxDefender/status/1999508734318391400)  2025-12-12T15:56Z [---] followers, [--] engagements


"@saylordocs No 250k @ 6% dividend yield can buy two bottles of Chateau Lafite Rothschild every month. Far more enjoyable than a shitbox 911"  
[X Link](https://x.com/DCVaxDefender/status/1999516160589431196)  2025-12-12T16:26Z [---] followers, [--] engagements


"$NWBO: Understanding the Advent "Validation Manager" Hire and Why It Signals Preparation for Global Commercial Manufacturing There is a lot of confusion in biotech investing about what "validation" actually is and why companies hire high-level validation leadership at specific moments. The new Advent Bioservices posting for a Validation Manager is not a sign of delay disorganization or any kind of regulatory bottleneck. It is a signal that Sawston is preparing for the next phase of operations: commercial-scale manufacturing under multiple regulatory regimes including the FDA. Sawston already"  
[X Link](https://x.com/DCVaxDefender/status/1999521236263620725)  2025-12-12T16:46Z [---] followers, [----] engagements


"@d_stock07734 @ATLnsider Yes and to protect our IP as well as maintain comparative advantage we are keeping manufacturing in house instead of outsourcing to CDMO. Along with validation manager in the UK we are seeing the beginnings of a commercial giant like Amgen Merck Moderna or Pfizer"  
[X Link](https://x.com/DCVaxDefender/status/1999626582768472276)  2025-12-12T23:45Z [---] followers, [--] engagements


"@ChristianVogl12 @mrs_danderfluff @HOUrbanist My 70s house is a clean room. It can be done by sealing attic junction boxes leaky windows and all other ways outdoor air infiltrate to conditioned space. When I moved in we had 70% humidity in winter but no longer. https://x.com/i/status/1998403862906950019 When I talk about clean rooms manufacturing and NWBO I am not speaking hypothetically as I literally live in one with my wife and two French Bulldogs. After sealing my disco-era house from top to bottom and running HEPA filtration our indoor air is basically clean-room https://t.co/X76JNZh23i"  
[X Link](https://x.com/DCVaxDefender/status/2000030569686499554)  2025-12-14T02:30Z [---] followers, [--] engagements


"Narrow market high risk and zero immune memory so vastly inferior to dendritic-cell-based immunotherapies like $NWBO DCVax-L and their Roswell Park portfolio. Antibody-drug conjugates (ADCs) are leaky chemo delivery systems. They are complex to manufacture brittle to error and small mistakes can be fatal in patients. ADCs only work in antigen-rich immunogenic "hot" tumors and create no durable immune memory which means they become ineffective when tumors downregulate their targets. Merck will pay extraordinary sums for inferior technology because Keytruda margins will soon be destroyed. How"  
[X Link](https://x.com/DCVaxDefender/status/2001700813488435356)  2025-12-18T17:07Z [---] followers, [----] engagements


"@RIP_GOP1234 BP are bureaucratic organizations. They will move on $NWBO when they are forced. That happens after MHRA approves DCVax for newly diagnosed and recurrent glioblastoma. Management have no reason to sell controlling interest at depressed prices. There will be a bidding war"  
[X Link](https://x.com/DCVaxDefender/status/2001733923244589096)  2025-12-18T19:18Z [---] followers, [---] engagements


"@ElvirPons In my opinion management should not get any additional annual cash bonuses until we are net positive on the balance sheet. They have already earned enormous amounts of equity-based compensation. If no buyout additional front line staff are needed to grow $NWBO post approval"  
[X Link](https://x.com/DCVaxDefender/status/2003178867964744004)  2025-12-22T19:00Z [---] followers, [----] engagements


"@CscottLawyer @ElvirPons I am not going to spend my Christmas week arguing that the world isn't flat. Enjoy yourself"  
[X Link](https://x.com/DCVaxDefender/status/2003192577236042238)  2025-12-22T19:55Z [---] followers, [---] engagements


"Are Chanel Louis Vuitton and all these brands really still luxury If middle-class people have them then how are they luxury They are not since shareholders in these companies want it accessible. What killed Halston is now standard business practice today"  
[X Link](https://x.com/DCVaxDefender/status/2003220603117965325)  2025-12-22T21:46Z [---] followers, [---] engagements


"@ButlerCabin1894 How many of these man children have a diver or driver watch with their suit Those are literally a sporting tool not a dress watch which should have a leather band and no bezel What's next expensive hiking boots Men today were never taught how to dress appropriately"  
[X Link](https://x.com/DCVaxDefender/status/2003226574724956317)  2025-12-22T22:10Z [---] followers, [--] engagements


"Now it's Frank Sinatra 24/7 for #Christmas2025 https://youtu.be/0iQNrtNu5I8si=kz95OBj0tNJlobx7 https://youtu.be/0iQNrtNu5I8si=kz95OBj0tNJlobx7"  
[X Link](https://x.com/DCVaxDefender/status/2003621644301226334)  2025-12-24T00:20Z [---] followers, [---] engagements


"Coming out of the [----] $NWBO ASM as a shareholder since early [----] I was frustrated. Yes we are moving forward with Grade C cleanrooms but relocating them within the Sawston facility and reducing initial scope to manage cash burn and minimize dilution. At first glance that feels slow and not ideal for a commercial launch. Digging deeper this traces back to a disastrous legacy contractor situation. The FACTOR/Flaskworks GMP vendor relationship dates to [----] before current management and before NWBO acquired Flaskworks in [----]. There was no executed SOW. The vendor went off-scope redesigned"  
[X Link](https://x.com/DCVaxDefender/status/2006031460893950074)  2025-12-30T15:55Z [---] followers, [----] engagements


"@KaareJohnson @ValentinaForUSA Not long ago they said "No Irish Need Apply." GFYS @ValentinaForUSA"  
[X Link](https://x.com/DCVaxDefender/status/2006136940228198592)  2025-12-30T22:54Z [---] followers, [--] engagements


"MAA includes both newly diagnosed and recurrent glioblastoma. Both are statistically significant and clinically proven in $NWBO Landmark PIII Trial. The question will be whether a label expansion out of the gate with post approval monitoring required for added indications such as Grade III Astrocytoma. DCVax has zero toxicity so doing this makes sense for patients and regulators. https://twitter.com/i/web/status/2006419627291619367 https://twitter.com/i/web/status/2006419627291619367"  
[X Link](https://x.com/DCVaxDefender/status/2006419627291619367)  2025-12-31T17:38Z [---] followers, [----] engagements


"@smith348572 Remember 5/10/2022. No halts on OTC. It is not an exchange but a decentralized quotation network. FINRA only halts OTC for overseas corporate actions not volatility. No Circuit Breaker for $NWBO"  
[X Link](https://x.com/DCVaxDefender/status/2007279538548683102)  2026-01-03T02:35Z [---] followers, [---] engagements


"In terms of relationship to the Mississippi River itself thus ability to see / interact with it as a pedestrian: New Orleans Memphis Minneapolis St Louis If St Louis had removed I-70 through its downtown then it would be ranked higher but it is still very much disconnected from the river given access blocked by industrial use. https://twitter.com/i/web/status/2010140249314521358 https://twitter.com/i/web/status/2010140249314521358"  
[X Link](https://x.com/DCVaxDefender/status/2010140249314521358)  2026-01-11T00:02Z [---] followers, [---] engagements


"@UrbanCourtyard So the thesis is basically: take Pruitt-Igoe towers make them a bit shorter slap mansard roofs on top and arrange them into a square Instead of "towers in the park" it's now "towers around a park." Not innovation rather it's modernist failure with better branding"  
[X Link](https://x.com/DCVaxDefender/status/2010515380536586722)  2026-01-12T00:53Z [---] followers, [--] engagements


"Your whole idea collapses in real life. That "courtyard park" will not be a park rather it wil be: - the dog bathroom - the kid noise zone - an echo chamber of amplified sound - panopticon Wrong scale. Zero privacy. Constant surveillance. It's just top-down modernist topology with Second Empire stylistic vibes imposed on cities. https://twitter.com/i/web/status/2010518979412938818 https://twitter.com/i/web/status/2010518979412938818"  
[X Link](https://x.com/DCVaxDefender/status/2010518979412938818)  2026-01-12T01:07Z [---] followers, [--] engagements


"Yes condos are ideal for foreign real estate speculation. Canadian real estate market has been a disaster for over a decade due to this reason along with growth boundaries in cities like Toronto and Vancouver. Calgary does not have land locked up like in Ontario or British Columbia but they still operate under the same market incentives which steer development into condos over single family detached homes. https://twitter.com/i/web/status/2010915046180769994 https://twitter.com/i/web/status/2010915046180769994"  
[X Link](https://x.com/DCVaxDefender/status/2010915046180769994)  2026-01-13T03:21Z [---] followers, [---] engagements


"So why is Chicago still treating the lakefront like a sacred museum Develop the lakefront. Build mixed-income high-rises with 20-30% affordable units parks transit and retail. Expand the tax base. Create real family housing in the most desirable location. Right now the only people who truly enjoy the lakefront daily are the wealthy households who already live next to it. The lakefront is an asset. If you want a middle class electorate then the solution is obvious. https://twitter.com/i/web/status/2011128813728538978 https://twitter.com/i/web/status/2011128813728538978"  
[X Link](https://x.com/DCVaxDefender/status/2011128813728538978)  2026-01-13T17:30Z [---] followers, [---] engagements


"@JohnSmith410846 @chisportsfan442 @jacobinfante24 City of Chicago cannot sell the land. Supreme Court prevents any development on the lakefront. Only Illinois legislature can override. This is why Soldier's Field will never be a good location for NFL as it's impossible to build anything around it. https://www.illinoiscourts.gov/News/681/Illinois-Supreme-Court-History-Montgomery-Ward-and-the-Chicago-Lake-Front/news-detail/ https://www.illinoiscourts.gov/News/681/Illinois-Supreme-Court-History-Montgomery-Ward-and-the-Chicago-Lake-Front/news-detail/"  
[X Link](https://x.com/DCVaxDefender/status/2012280243461992631)  2026-01-16T21:46Z [---] followers, [--] engagements


"@AJManaseer Yes they should also override the Supreme Court and allow a new stadium on the lakefront with residential and commercial real estate. https://www.illinoiscourts.gov/News/681/Illinois-Supreme-Court-History-Montgomery-Ward-and-the-Chicago-Lake-Front/news-detail/ https://www.illinoiscourts.gov/News/681/Illinois-Supreme-Court-History-Montgomery-Ward-and-the-Chicago-Lake-Front/news-detail/"  
[X Link](https://x.com/DCVaxDefender/status/2012281493758898250)  2026-01-16T21:51Z [---] followers, [---] engagements


"@andrewcaravello @clausknielsen London does 4B/day. US equities do $600B/day. 100x difference. If $NWBO uplists it's US markets as that's where the liquidity and biotech capital actually exist"  
[X Link](https://x.com/DCVaxDefender/status/2012946933229211705)  2026-01-18T17:55Z [---] followers, [---] engagements


"@clausknielsen @andrewcaravello Most do not understand Europe fragmented and illiquid compared to US markets. Less depth worse price discovery. London uplist would be downgrade as US biotechs go to NASDAQ. In fact $NWBO has been on LSE as ADR since [----] and nobody knew because it never clears a trade πŸ€ͺ"  
[X Link](https://x.com/DCVaxDefender/status/2012950843343905170)  2026-01-18T18:10Z [---] followers, [---] engagements


"@Scaramucci Patron Saint of Long Haul Truckers Who Drink Ptrus Flexing $50k+ of trophy wine while heading to the "inequality summit." πŸ˜±πŸ˜†πŸ₯‚"  
[X Link](https://x.com/DCVaxDefender/status/2012962986072174699)  2026-01-18T18:59Z [---] followers, [---] engagements


"@2024dion You can blame Urban Renewal and White Flight (Mapping Decline by Colin Gordon) but St Louis' elites left town while local officials fought zero sum game. Peirce Reports in Post Dispatch warned of the outcome we see today. https://www.nealpeircefoundation.org/peirce-reports-archive/ https://www.goodreads.com/book/show/3045503-mapping-decline https://www.nealpeircefoundation.org/peirce-reports-archive/ https://www.goodreads.com/book/show/3045503-mapping-decline"  
[X Link](https://x.com/DCVaxDefender/status/2012965354494951713)  2026-01-18T19:08Z [---] followers, [---] engagements


"LSE and Stuttgart behave like an ADR: a thin foreign wrapper that tracks the US common and does not create real liquidity for the actual domestic listing where the company actually raises capital Calling that an "uplist" path for $NWBO is still nonsense"  
[X Link](https://x.com/DCVaxDefender/status/2012966758043308100)  2026-01-18T19:14Z [---] followers, [---] engagements


"@JacobPlieth @singhlosophy @Sanctuary_Bio You mean the company with GMP approval $NWBO vs the one which got CRL $IBRX because it couldn't manufacture a basic cytokine Must be great to not create anything then spend your time attacking a company published in JAMA and Nature"  
[X Link](https://x.com/DCVaxDefender/status/2013366778584301817)  2026-01-19T21:43Z [---] followers, [----] engagements


"@UrbanCourtyard @fhjckaka Here comes an urban planner to save St Louis"  
[X Link](https://x.com/DCVaxDefender/status/2013457034042032253)  2026-01-20T03:42Z [---] followers, [--] engagements


"@BulwarkOnline That's Davos"  
[X Link](https://x.com/DCVaxDefender/status/2013647474670403976)  2026-01-20T16:19Z [---] followers, [---] engagements


"@mnolangray Detroit has Dan Gilbert. St Louis has Paul McKee"  
[X Link](https://x.com/DCVaxDefender/status/2013661014428959100)  2026-01-20T17:12Z [---] followers, [----] engagements


"@adonispara With a negroni and Nat Sherman"  
[X Link](https://x.com/DCVaxDefender/status/2013671197049815293)  2026-01-20T17:53Z [---] followers, [---] engagements


"@thealepalombo Also a flat in Monti neighborhood of Roma"  
[X Link](https://x.com/DCVaxDefender/status/2013711016022929738)  2026-01-20T20:31Z [---] followers, [--] engagements


"This is a tired talking point. Louisiana's insurance problem is not billboard attorneys. It is poverty + uninsured drivers + crash frequency + drunk driving + theft + and catastrophic flooding/storm losses. Those factors drive claim frequency and severity and that is what insurers price. Attorneys do not cause wrecks or floods. They exist because people get hurt and need recourse. And a lot of people get hurt because driving in New Orleans is extremely dangerous. If you remove the ability to sue then you are not fixing the risk rather you are just protecting insurers."  
[X Link](https://x.com/DCVaxDefender/status/2014032898685300888)  2026-01-21T17:50Z [---] followers, [--] engagements


"@GavinNewsom Repeal the Patriot Act abolish @DHSgov @TSA @ICEgov. America was far safer before [----]. It was certainly a more civilized country"  
[X Link](https://x.com/DCVaxDefender/status/2015253112416608670)  2026-01-25T02:39Z [---] followers, [--] engagements


"@marcorasi1960 AMAZING One of my favorite places in New Orleans"  
[X Link](https://x.com/DCVaxDefender/status/2015962315766538708)  2026-01-27T01:37Z [---] followers, [--] engagements


"Funny now selective outrage works. Crime was rampant for years under Bobby Jindal while he hollowed out healthcare cut higher ed to the bone and left the state broke and bleeding people. This did not happen in a vacuum. Post-Katrina was Louisiana's chance to rebuild and Bobby Jindal squandered it by gutting healthcare and education while papering over deficits. You are looking at long-term institutional damage not a sudden crime wave that started this year. You do not get to memory-hole a decade of policy failure and pretend this is some sudden mystery. If you actually care about public"  
[X Link](https://x.com/DCVaxDefender/status/2016196049715564910)  2026-01-27T17:06Z [---] followers, [--] engagements


"@GoneGoodguy @d_stock07734 @maxstradamus21 Merck's acquisition history combined with reported DCVax combination studies using pembrolizumab suggests $NWBO DCVax is already being evaluated as a potential foundational antigen-presentation platform. Regulatory validation would materially elevate its strategic relevance"  
[X Link](https://x.com/DCVaxDefender/status/2016913143125967017)  2026-01-29T16:35Z [---] followers, [---] engagements


"My M340i will do [---] down the highway one-handed AC blasting dead stable like it's nothing and still have torque to keep going. That Boss shit is a museum piece that's fighting for its life at speeds (120) modern cars sleepwalk through. Absolute waste of money pure boomer cosplay unstable zero real performance"  
[X Link](https://x.com/DCVaxDefender/status/2017027699169022123)  2026-01-30T00:10Z [---] followers, [--] engagements


"Yes they are making connections and that's the problem. Hub-and-spoke is fragile carbon-intensive delay-prone systems design from the 1970s. One storm one crew issue one hub melts and half the country eats it. LAX is the purest example of US transportation failure: an irredeemable airport impossible to fix impossible to replace propped up as a single point of failure for passengers and freight. We concentrated half the West Coast's mobility and logistics into one carbon-spewing choke point and then act surprised when the system collapses. In addition small cities cant be served by rail is BS."  
[X Link](https://x.com/DCVaxDefender/status/2017302660987388092)  2026-01-30T18:23Z [---] followers, [---] engagements


"@jtsla4 Around 40% of silver demand comes from industry (electronics solar panels etc) so it's actually a high beta asset as it moves with the market. The market for silver is illiquid. In a recession you should not expect silver to be a safe haven"  
[X Link](https://x.com/DCVaxDefender/status/2017359889329274932)  2026-01-30T22:10Z [---] followers, [----] engagements


"@jtsla4 Commodities are inputs. Inputs are cyclical. Period. If something is primarily used to make other things its demand is tied to production capex and consumption. When the economy slows those fall. That's not ideology that's accounting. Never go full commodities. #OOTT"  
[X Link](https://x.com/DCVaxDefender/status/2017360478847054296)  2026-01-30T22:13Z [---] followers, [---] engagements


"@patrickwalsh14 @ATLnsider @glen_bwrhr42 Novartis shareholders disagree. $NWBO has potential for approval next week. https://www.novartis.com/uk-en/news/media-releases/novartis-kisqali-ribociclib-receives-mhra-authorisation-adjuvant-treatment-hrher2-early-breast-cancer-high-risk-recurrence-broad-population-patients https://www.novartis.com/uk-en/news/media-releases/novartis-kisqali-ribociclib-receives-mhra-authorisation-adjuvant-treatment-hrher2-early-breast-cancer-high-risk-recurrence-broad-population-patients"  
[X Link](https://x.com/DCVaxDefender/status/2017362533942779983)  2026-01-30T22:21Z [---] followers, [---] engagements


"@L_33_H @BMW @BMWGroup F30 better especially B58 vs N55"  
[X Link](https://x.com/DCVaxDefender/status/2018743739808723411)  2026-02-03T17:49Z [---] followers, [--] engagements


"@thealepalombo In the next few years I plan on buying a flat in Monti and villa outside Florence. The Italian people are the most welcoming in Europe"  
[X Link](https://x.com/DCVaxDefender/status/2018747513499505114)  2026-02-03T18:04Z [---] followers, [----] engagements


"Complaining about property taxes in a state with zero income tax and zero capital gains tax is peak small-picture thinking. If you have any equity at all you are coming out millions ahead in Texas. The math is not hard: stop whining about the cost of the concrete and start appreciating that the state stays out of your paycheck and your portfolio. If you want to be taxed on your labor and your investments then move to New Jersey New York California or Illinois. https://twitter.com/i/web/status/2018931303178002628 https://twitter.com/i/web/status/2018931303178002628"  
[X Link](https://x.com/DCVaxDefender/status/2018931303178002628)  2026-02-04T06:15Z [---] followers, [---] engagements


"Dr. Balakumaran's extensive background includes transformative roles such as the former Chief Medical Officer at Allogene and the Product Development Lead at Merck. At Merck he was recognized as a Merck Distinguished Scientist and played a pivotal role in the development of Keytruda a broad-spectrum cancer drug. Trained in clinical and laboratory research at the National Institutes of Health (NIH) he has built a robust foundation in medical science. https://www.cancerchecklabs.com/about-us/meet-the-team https://www.cancerchecklabs.com/about-us/meet-the-team"  
[X Link](https://x.com/DCVaxDefender/status/2019183219015344588)  2026-02-04T22:56Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

@DCVaxDefender Avatar @DCVaxDefender autologous assassin πŸ‡ΊπŸ‡ΈπŸ‡¨πŸ‡±βšœοΈπŸ΄β€β˜ οΈ

autologous assassin πŸ‡ΊπŸ‡ΈπŸ‡¨πŸ‡±βšœοΈπŸ΄β€β˜ οΈ posts on X about $nwbo, $ibrx, if you, in the the most. They currently have [---] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

  • [--] Week [-----] +198%
  • [--] Month [------] +260%
  • [--] Months [-------] +34%

Mentions: [--] #

Mentions Line Chart

  • [--] Week [--] -10%
  • [--] Month [--] +80%
  • [--] Months [---] +38%

Followers: [---] #

Followers Line Chart

  • [--] Week [---] +0.94%
  • [--] Month [---] +1.40%
  • [--] Months [---] +21%

CreatorRank: [-------] #

CreatorRank Line Chart

Social Influence

Social category influence finance 28% stocks 9% travel destinations 6% technology brands 3% countries 2% fashion brands 1% luxury brands 1% cryptocurrencies 1% exchanges 1% automotive brands 1%

Social topic influence $nwbo #4, $ibrx 23%, if you 5%, in the 5%, approval #167, we are 4%, liquidity 4%, london 4%, st louis 4%, the world 3%

Top accounts mentioned or mentioned by @andrewcaravello @grok @bambossie81 @elvirpons @kryptypop @atlnsider @jacobyorkndxt @dwpamont @smith348572 @chriscuomo @tonyverazzanno @flemmingbruce @dstock07734 @urbancourtyard @clausknielsen @thealepalombo @jtsla4 @thomasowenmcca1 @albturmnymkrs @stonkmasterj

Top assets mentioned ImmunityBio, Inc. Common Stock (IBRX) Merck & Co., Inc. (MRK) Palantir Technologies Inc. (PLTR) HCA Healthcare Inc (HCA) Booz Allen Hamilton Holding, Corp. (BAH)

Top Social Posts

Top posts by engagements in the last [--] hours

"Airports are monuments to American failure in transportation planning. We force [------] mile trips onto the most carbon-intensive least resilient mode then celebrate bigger terminals while Europe rides electrified rail through heat waves with their dogs and dignity intact. Security theater hub fragility weather cascades massive CO thus this is not "progress." Its systems malpractice. Let's not memory-hole this: Carl Icahn strip-mined TWA hollowed out St. Louis as a global hub and walked away richer while an entire regional air network collapsed. That's the airline model of financial extraction"
X Link 2026-01-30T16:53Z [---] followers, [----] engagements

"Calling property tax a tax on unrealized gains is economically illiterate. Full stop. Property tax is not a wealth tax not a capital-gains tax and not some sneaky Zillow hallucination. It is a land-use and service-recovery tax on immobile assets that continuously consume public infrastructure. If you dont understand that distinction you shouldnt be opining on tax policy [--]. Property value paper wealth Your homes assessed value is not a random spreadsheet number. It reflects real cumulative public investment: [--] Roads and resurfacing 2.Water sewer and stormwater systems that last [-----] years"
X Link 2026-01-30T17:27Z [---] followers, [----] engagements

"@albtur_mnymkrs @StonkMasterJ King's College isn't a commercial GMP covered under $NWBO MIA. Management would not allocate opex on this hire if no revenue coming soon. Her credentials are from Kings College and HCA Healthcare which is one of the largest private hospital systems in the world. Qualified"
X Link 2026-02-09T20:14Z [---] followers, [---] engagements

"As an American living in Texas (no state income tax) the math is very different for me. I am happy to buy property in Italy and spend money supporting wineries restaurants artisans but I am not becoming an Italian tax resident or moving my IRA into a foreign tax system. Under Schengen rules I can visit up to [--] days in any 180-day period without triggering residency. That's more than enough for a seasonal base. No need to overcomplicate it. I analyzed every coastal town in Italy on a 1M budget. Taxes. Airports. What 1M actually buys you in each location. I cross-checked every detail with two"
X Link 2026-02-11T21:42Z [---] followers, [--] engagements

"@EWErickson Most Americans do not have a 401K or enough savings to retire. Appealing to the top 1% does not work as we are also for locking up pedophiles"
X Link 2026-02-12T00:42Z [---] followers, [---] engagements

"@fendyluck Do you know what it means to miss New Orleans https://youtu.be/m4jU8IQK5b0si=r7Jg0TVJyST2lsv2 https://youtu.be/m4jU8IQK5b0si=r7Jg0TVJyST2lsv2"
X Link 2026-02-14T01:56Z [---] followers, [---] engagements

"What's the hold up for $NWBO Honestly we do not know as there's no comparable baseline. DCVax-L had [--] CHM meetings [--] months apart. No other MHRA approval has followed that path. N=1 means not enough data to do any comparative analysis. What we do know: 1) Data is unambiguously excellent (HR 0.80/0.58 p0.002/0.001) 2) Better stats than Optune which FDA approved YESTERDAY 3) SAP pre-specified before data lock so no data dredging 4) Manufacturing already approved 5) No rejection language from MHRA 6) Company burning additional capex (Flaskworks Class C) and opex (patient hire & Pittsburgh"
X Link 2026-02-13T17:12Z [---] followers, [----] engagements

"@DWpaMont Then I guess it's @UofIllinois for $NWBO shareholders"
X Link 2026-02-14T03:35Z [---] followers, [---] engagements

"You cannot ethically randomize dying patients to placebo. That's why every UK-approved CAR-T got approved on single-arm trials with no control group. GBM patients face the same reality which $NWBO DCVax-L trial proved as 90% crossed over because they refused to die on placebo. For context UK-approved CAR-Ts with NO control group: - Kymriah - Yescarta - Tecartus - Breyanzi - Abecma - Carvykti - Aucatzyl After MHRA approved Aucatzyl (an autologous not allogeneic CAR-T) NICE approved it for NHS reimbursement. This all happened only a few months apart in [----]. Aucatzyl had: - Single-arm trial -"
X Link 2026-02-14T16:56Z [---] followers, [---] engagements

"I need to get the Pol Roger ready for $NWBO approval"
X Link 2026-02-09T20:21Z [---] followers, [----] engagements

"Management has stated several times they are going to market with the approved open system manufacturing process which MHRA approved in [----]. This requires Class B (ISO [--] at rest) which $NWBO built in Sawston at great expense. The Class C cleanrooms (ISO [--] at rest) and Flaskworks bridging study is not delaying DCVax MAA. If ISO [--] manufacturing was gating approval that's material and would be disclosed in SEC filings with the many other risks outlined. In fact management said in PR that the approved MIA license was a prerequisite for MAA approval. The same has never been said about Flaskworks"
X Link 2026-02-13T19:25Z [---] followers, [---] engagements

"@grok Market makers respond to order flow. If there's no liquidity in the $NWBO UK listing there's nothing to hedge nothing to absorb nothing to "manipulate." Price discovery happens where: - Volume is highest - Spreads are tightest - Institutions transact For Northwest Biotherapeutics that's the US OTC market not a thin UK side listing. If meaningful buying showed up in the UK arbitrage desks would immediately connect it to the US market and close any pricing gap. If there's no volume there's no signal no pressure no structural effect. No liquidity = no mechanism"
X Link 2026-02-15T17:14Z [---] followers, [--] engagements

"The market infrastructure in London and Stuttgart is real. It has aspects which are far superior to OTCQB. Yet the implication that it overrides lack of $NWBO European liquidity is not. Auctions settlement rules and takeover-code tweaks do not create demand rather they just process it. Without sustained European volume US OTC remains the price discovery venue. Order flow moves the price not market plumbing. https://twitter.com/i/web/status/2023086909606510631 https://twitter.com/i/web/status/2023086909606510631"
X Link 2026-02-15T17:28Z [---] followers, [--] engagements

"Reminder for fellow $NWBO shareholders: In [----] Parliament asked MHRA multple times what's going on with the DCVax approval process The answer was under evaluation. No signal of failure. No rejection language. In addition MHRA already approved DCVax manufacturing. DCVax trial was highly statistically significant. No systemic safety issues. Terminal orphan indication. If there were a fatal problem MHRA would not be saying under review to Parliament instead they would be signaling additional requirements. We would have heard about fatal issues long ago. They do not suddenly manifest after two"
X Link 2026-02-13T03:45Z [---] followers, [----] engagements

"Shorts reacting to $NWBO approval"
X Link 2026-02-15T00:47Z [---] followers, [---] engagements

"For anyone unfamiliar arbitrage is when traders buy a stock in one market and simultaneously sell it in another to capture a price difference. If $NWBO were truly trading at $1.78 in London while its $0.24 in the US professionals would close that gap immediately. Persistent 600% spreads NEVER exist in functioning markets because capital eliminates them immediately. Before repeating structural claims online it's worth understanding how cross-market pricing actually works. https://twitter.com/i/web/status/2023084505079165135 https://twitter.com/i/web/status/2023084505079165135"
X Link 2026-02-15T17:18Z [---] followers, [--] engagements

"$IBRX pumping NK/IL-15 as a GBM breakthrough completely ignores basic tumor biology. Expanding NK cells solving glioblastoma. It also ignores the approach that works which $NWBO proved in PIII peer review published in JAMA. GBM is one of the most heterogeneous infiltrative tumors in human biology. Tumor cells are constantly changing and invading normal brain tissue. You do not fix that with a generic cytokine bath rather you need patient-specific antigen presentation and real T-cell priming. On top of that GBM actively suppresses NK pathways: HLA-E/HLA-G expression and TGF- in the tumor"
X Link 2025-11-29T01:53Z [---] followers, [---] engagements

"@jersey_ham So sorry to hear that David 😒"
X Link 2025-11-29T04:45Z [---] followers, [---] engagements

"Yeah it is wild because the entire IL-15 / $IBRX premise collapses the moment you apply basic tumor immunology and compare it to what $NWBO is actually doing. IL-15 expands NK cells and expands already-existing effector/memory CD8 T-cells and some memory/activated CD4 helper T-cells. It cannot create new tumor-specific cytotoxic T-cells because only dendritic cells can prime nave T-cells with the tumors full antigenic blueprint. In GBM (and most metastatic heterogeneous cancers): [--]. Dendritic cells are suppressed and depleted [--]. CD4 helpers are dysfunctional and unprimed [--]. CD8 cytotoxic"
X Link 2025-11-29T05:47Z [---] followers, [----] engagements

"Throwing [---] octane gasoline into a blown engine will not win the Daytona [---]. @andrewcaravello correct about $IBRX which does not target tumor antigens. It will not work for Glioblastoma or any metastatic cancer indication. $NWBO has proven results. https://x.com/DCVaxDefender/status/1994644461876371585t=0bz5gV4CuAt4a3SohUPyfA&s=19 https://x.com/DCVaxDefender/status/1994644461876371585t=0bz5gV4CuAt4a3SohUPyfA&s=19 @smith348572 @weldeiry @AlMusella @DrPatSoonShiong @ChrisCuomo @WIN_Consortium @MHRAgovuk Yeah it is wild because the entire IL-15 / $IBRX premise collapses the moment you apply"
X Link 2025-11-29T16:58Z [---] followers, [----] engagements

"@BAMBossie81 Keep trolling $NWBO. We are immune unlike patients getting IL-15 1B $IBRX shares + cytokine that does nothing for metastatic indications. Another $CVM πŸ“‰πŸ“‰πŸ“‰πŸ“‰ πŸ˜†πŸ˜†πŸ˜†πŸ˜† https://x.com/DCVaxDefender/status/1994813211908931816t=qL6vsOsJ_K6Gjmg1NZzTAw&s=19 @BAMBossie81 Throwing [---] octane gasoline into a blown engine will not win the Daytona [---]. @andrewcaravello correct about $IBRX which does not target tumor antigens. It will not work for Glioblastoma or any metastatic cancer indication. $NWBO has proven results. https://t.co/v0rDWRxMuu https://t.co/1JHBNtYJdf"
X Link 2025-11-29T19:13Z [---] followers, [----] engagements

"1/2 Your response comparing $IBRX to $NWBO contains a great deal of technical decoration but none of it addresses the single scientific question that determines whether a cancer immunotherapy has any chance of working. How does the platform generate new tumour specific T cell clones. If a treatment cannot create new cytotoxic T cells that recognise the patients own tumour antigens then it cannot produce lasting control of any metastatic cancer. Nothing in your explanation shows that this is happening with the Bioshield system. The core scientific defect remains untouched. Cancer disables"
X Link 2025-11-29T20:17Z [---] followers, [---] engagements

"2/2 $NWBO $IBRX You also do not address the lack of any overall survival evidence for Anktiva or for the larger Bioshield concept. There is no validation that any of the described circuitry produces a survival benefit in any metastatic indication. The pivotal study for Anktiva lacked a randomised control arm lacked a p value for survival lacked a comparison to Bacillus Calmette Guerin alone and was subsequently refused for filing by the FDA for other subtypes. There is no evidence that the approach has altered the natural history of any solid tumour. By contrast dendritic cell therapy has"
X Link 2025-11-29T20:19Z [---] followers, [---] engagements

"The immune system army is blind exhausted lost and untrained so let's just give them cocaine and hope something good happens. That is literally the $IBRX BioShield model"
X Link 2025-11-29T20:31Z [---] followers, [---] engagements

"@andrewcaravello @BillMur81205942 @MK2forU Multikine and Rindopepimut looked promising then failed in Phase III trials. Metastatic tumors evolve so you must monitor populations over time. If $IBRX investors do not understand basic concepts then they should not be investing in the extremely risky biotechnology sector"
X Link 2025-11-29T21:38Z [---] followers, [--] engagements

"$IBRX $NWBO Bad biology is the enemy. There is no "unity" between a treatment that cannot succeed in solid tumours and a platform that was specifically built to solve the immunologic collapse that solid tumours create. Anktiva plus BCG is a bladder regimen where BCG does the work. DCVax is an antigen-instruction platform with Overall Survival data in an immunosuppressive cold solid tumour. These technologies are not comparable and they do not support each other. One amplifies dysfunction whereas the other corrects it. One has zero population data in any solid metastatic tumour and the other"
X Link 2025-11-30T00:57Z [---] followers, [---] engagements

"$IBRX $NWBO What Dr. Soon-Shiong said on NewsNation deserves a calm scientific correction because the claims being circulated online are not supported by oncology immunology or pathology. They are alarming but not accurate. [--]. "Spike protein inside tumors" is not a documented phenomenon. There is no peer-reviewed evidence showing spike protein accumulating in tumors driving tumor biology or altering oncogenic pathways. If such a finding existed it would have been published immediately by major academic centers. It has not been observed by pathologists tumour boards or molecular labs. The"
X Link 2025-11-30T16:50Z [---] followers, 11.8K engagements

"@cjp1816 Fidelity are #1 choice for employer-funded retirement accounts By design they restrict customers from making their own decisions. Move to Schwab which allows $NWBO orders well above current bid ask. These ladder sells force buyers to meet us at our desired price. πŸ’£πŸš€πŸ“ˆπŸ‘©πŸš€πŸŒ›"
X Link 2025-12-01T17:38Z [---] followers, [---] engagements

"@BAMBossie81 @KryptyPop @grok How does $IBRX get to 1B shares without dilution"
X Link 2025-12-01T18:47Z [---] followers, [---] engagements

"@BAMBossie81 @KryptyPop @grok I worked at one of the top research hospitals in the world. Keep shilling $IBRX for a billionaire simp"
X Link 2025-12-01T19:02Z [---] followers, [---] engagements

"@BAMBossie81 @KryptyPop @grok $IBRX $NWBO https://x.com/DCVaxDefender/status/1994813211908931816t=fxZCz0zUT35P0xMfDlNkZQ&s=19 @BAMBossie81 Throwing [---] octane gasoline into a blown engine will not win the Daytona [---]. @andrewcaravello correct about $IBRX which does not target tumor antigens. It will not work for Glioblastoma or any metastatic cancer indication. $NWBO has proven results. https://t.co/v0rDWRxMuu https://t.co/1JHBNtYJdf https://x.com/DCVaxDefender/status/1994813211908931816t=fxZCz0zUT35P0xMfDlNkZQ&s=19 @BAMBossie81 Throwing [---] octane gasoline into a blown engine will not win"
X Link 2025-12-01T19:17Z [---] followers, [---] engagements

"@ATLnsider Do you think there could be merit to $NWBO including [--] year survival data in their NICE evidence submission This would provide them additional QALYs"
X Link 2025-12-01T20:29Z [---] followers, [---] engagements

"@Investisco Congratulations I am now at 814K shares"
X Link 2025-12-01T21:18Z [---] followers, [---] engagements

"🚨 REALITY CHECK: $IBRX got REFUSED TO FILE by FDA for papillary NMIBC. 🚨 Same study FDA "approved" before Now insufficient for regulatory review. Translation: The treatment does not work. Soon-Shiong blaming FDA = classic scam playbook. No real efficacy in the population (Cohort C) that matters. Just a billionaire pumping vaporware. Meanwhile $NWBO has Phase III JAMA-published survival data in GBM with 10+ year survivors. IL-15 expands dysfunctional cells. DCVax rebuilds immune intelligence. One has evidence. One has a Refusal to File. Stop buying the hype. You will lose your money"
X Link 2025-12-01T21:34Z [---] followers, [----] engagements

"🚨 $IBRX's PR Response Shows Classic Red Flags: "FDA gave us unanimous guidance in January" "We're shocked by this inconsistent response" "Former FDA official says it's incomprehensible" REALITY CHECK: If Cohort B data were adequate FDA would have filed it. RTF = fundamental deficiencies in the application. FDA approved CIS+papillary (Cohort A) for a small high-risk population with limited options. But papillary-ONLY (Cohort B) which represents 90% of NMIBC patients REFUSED TO FILE. The implication: IL-15 may not work without the CIS component driving the immune response. Why this matters:"
X Link 2025-12-01T21:46Z [---] followers, [---] engagements

"1/2 $XBI $NWBO 🚨 A Complete Timeline of $IBRX Regulatory Failures 🧡 ImmunityBio claims to be developing treatments for glioblastoma and other cancers. Here's what investors need to know about their actual track record with regulators: MAY 2023: Complete Response Letter (CRL) FDA rejects BLA due to MANUFACTURING DEFICIENCIES at third-party contract manufacturers Not clinical data issues as they could not meet basic GMP standards. Stock crashes 50% overnight ($6.22 $3.39) Source: Fierce Pharma May [--] [----] OCTOBER 2023: BLA Resubmission Company addresses manufacturing issues FDA accepts"
X Link 2025-12-01T22:11Z [---] followers, [----] engagements

"2/2 $XBI $NWBO $IBRX The Scientific Problem: IL-15 is an innate immune cytokine that expands NK cells and existing T dysfunctional cells. IBRX CANNOT: πŸ“‰Create new tumor-specific T cell responses πŸ“‰Provide antigen recognition for heterogeneous tumors πŸ“‰Build durable adaptive immunity without proper DC priming The Cohort A approval (CIS patients) likely succeeds because CIS creates local inflammation that provides some antigenic stimulation. Remove that (Cohort B = papillary-only) and the mechanism falls apart. GLIOBLASTOMA CLAIMS: ImmunityBio promotes ongoing GBM research. What $IBRX has in"
X Link 2025-12-01T22:22Z [---] followers, [----] engagements

"@JacobYorkndxt $IBRX does not create immune memory. Mouse studies mean nothing for Glioblastoma. This is damaging to patients and investors"
X Link 2025-12-01T22:59Z [---] followers, [---] engagements

"@truedat999 Keep pumping mouse studies $IBRX https://x.com/DCVaxDefender/status/1995628786013061411t=6Xf4gHtkZovzj8w7a7359w&s=19 @JacobYorkndxt $IBRX does not create immune memory. Mouse studies mean nothing for Glioblastoma. This is damaging to patients and investors. https://t.co/Msi1EOpfNv https://x.com/DCVaxDefender/status/1995628786013061411t=6Xf4gHtkZovzj8w7a7359w&s=19 @JacobYorkndxt $IBRX does not create immune memory. Mouse studies mean nothing for Glioblastoma. This is damaging to patients and investors. https://t.co/Msi1EOpfNv"
X Link 2025-12-02T01:16Z [---] followers, [---] engagements

"@TonyVerazzanno You are not voting yes to add [---] million $NWBO shares. You are voting yes to amend the Articles of Incorporation to make 2.6B the maximum amount authorized. We have 100M authorized Class C shares and less than 1% have been sold. It's either amend Articles or Reverse Split"
X Link 2025-12-02T18:37Z [---] followers, [---] engagements

"@JacobYorkndxt Talking to @ChrisCuomo isn't a viable business plan for $IBRX"
X Link 2025-12-02T18:44Z [---] followers, [---] engagements

"@FlemmingBruce 😭 $IBRX 😭"
X Link 2025-12-02T18:49Z [---] followers, [---] engagements

"@TommyBaxendale @TonyVerazzanno @IrishMc67 To be clear "already over" does not mean anything was done incorrectly. Derivatives are never included in outstanding share counts. If anyone's to blame for this situation it's market makers swing traders and shorts which keep share price depressed. Not management's fault"
X Link 2025-12-02T22:38Z [---] followers, [--] engagements

"@peter_mantas And do what He picked these mfers"
X Link 2025-12-03T01:06Z [---] followers, [--] engagements

"$NWBO https://youtu.be/9_DSE3FSalMsi=Acq5aWI2HyMu-SEL https://youtu.be/9_DSE3FSalMsi=Acq5aWI2HyMu-SEL"
X Link 2025-12-03T05:18Z [---] followers, [---] engagements

"Survey says: [--] out of [--] $XBI investors who got a D+ biology prefer $IBRX over $NWBO and $MRK @andrewcaravello https://t.co/ycD0LrGamx @andrewcaravello https://t.co/ycD0LrGamx"
X Link 2025-12-04T16:29Z [---] followers, [----] engagements

"@siixandserello @SnackBioTech @FlemmingBruce @adamfeuerstein Unstoppable powerhouses do not get Complete Response Letters and Refusals to File from the FDA. $IBRX have been in a downward spiral since FDA found they couldn't even manufacture an off the shelf cytokine properly. Sued by shareholders. Lost. https://news.bloomberglaw.com/litigation/immunitybio-10-5-million-settlement-over-record-selloff-gets-ok https://news.bloomberglaw.com/litigation/immunitybio-10-5-million-settlement-over-record-selloff-gets-ok"
X Link 2025-12-05T01:09Z [---] followers, [---] engagements

"@TheSadvocate @TurdFNOLA5 They pay taxes every time they go to Home Depot"
X Link 2025-12-05T16:45Z [---] followers, [---] engagements

"$PLTR at a [---] P/E and [---] forward P/E straight comedy $430B market cap built on Alex Karp doing a full Tom-Cruise-on-coke routine while the company prints pennies per share. Meanwhile $NWBO DCVax is sitting on a platform that rewrites oncology extends survival in glioblastoma (something no Big Pharma has cracked in [--] years) runs fully automated manufacturing and plugs directly into the future of individualized medicine across every solid tumor. One is hype riding a fragile narrative. The other is a first-in-class regulator-aligned IP-fortified therapeutic with real clinical outcomes and"
X Link 2025-12-08T15:20Z [---] followers, [----] engagements

"Booz Allen $BAH earns $6.54/share runs cyber + intel for the US government has [--] years of mission-critical contracts and trades at a [--] PE with a $10.7B market cap. Palantir $PLTR earns $0.24/share sells dashboards + AI buzzwords and trades at a [---] PE with a $430B market cap because the CEO does a Twitch-streamer-on-cocaine routine. If the market is willing to give THAT a $400B valuation dont tell me NWBOs first-in-class clinically validated regulator-aligned immunotherapy platform is not worth tens of billions. The whole market is upside down"
X Link 2025-12-08T15:31Z [---] followers, [---] engagements

"Diversification is protection against ignorance. If you know what you are doing then it makes little sense"
X Link 2025-12-09T01:25Z [---] followers, [---] engagements

"We should NOT be asking $NWBO management or George to "reach out" to YouTubers meme-stock personalities or anyone sitting on the "Genius Board." NWBO is a clinical-stage biotech on the verge of real approvals real revenue and real global partnerships. This is not GME AMC or any other retail-driven circus. Management's focus needs to stay exactly where it is: regulators manufacturing scale-up reimbursement and strategic negotiations not chasing influencers on social media. Let's keep this community serious and aligned with the scale of what's coming. NWBO isn't a meme stock. It's a future"
X Link 2025-12-09T15:28Z [---] followers, [---] engagements

"@ElvirPons @DerrickEvans4WV Health savings accounts are not an alternative to health insurance. Simply a tax haven. If you have no income (poor) you already pay little to no tax. GOP does not want government spending or regulations on health because they think healthcare is a private responsibility"
X Link 2025-12-12T15:56Z [---] followers, [--] engagements

"@saylordocs No 250k @ 6% dividend yield can buy two bottles of Chateau Lafite Rothschild every month. Far more enjoyable than a shitbox 911"
X Link 2025-12-12T16:26Z [---] followers, [--] engagements

"$NWBO: Understanding the Advent "Validation Manager" Hire and Why It Signals Preparation for Global Commercial Manufacturing There is a lot of confusion in biotech investing about what "validation" actually is and why companies hire high-level validation leadership at specific moments. The new Advent Bioservices posting for a Validation Manager is not a sign of delay disorganization or any kind of regulatory bottleneck. It is a signal that Sawston is preparing for the next phase of operations: commercial-scale manufacturing under multiple regulatory regimes including the FDA. Sawston already"
X Link 2025-12-12T16:46Z [---] followers, [----] engagements

"@d_stock07734 @ATLnsider Yes and to protect our IP as well as maintain comparative advantage we are keeping manufacturing in house instead of outsourcing to CDMO. Along with validation manager in the UK we are seeing the beginnings of a commercial giant like Amgen Merck Moderna or Pfizer"
X Link 2025-12-12T23:45Z [---] followers, [--] engagements

"@ChristianVogl12 @mrs_danderfluff @HOUrbanist My 70s house is a clean room. It can be done by sealing attic junction boxes leaky windows and all other ways outdoor air infiltrate to conditioned space. When I moved in we had 70% humidity in winter but no longer. https://x.com/i/status/1998403862906950019 When I talk about clean rooms manufacturing and NWBO I am not speaking hypothetically as I literally live in one with my wife and two French Bulldogs. After sealing my disco-era house from top to bottom and running HEPA filtration our indoor air is basically clean-room https://t.co/X76JNZh23i"
X Link 2025-12-14T02:30Z [---] followers, [--] engagements

"Narrow market high risk and zero immune memory so vastly inferior to dendritic-cell-based immunotherapies like $NWBO DCVax-L and their Roswell Park portfolio. Antibody-drug conjugates (ADCs) are leaky chemo delivery systems. They are complex to manufacture brittle to error and small mistakes can be fatal in patients. ADCs only work in antigen-rich immunogenic "hot" tumors and create no durable immune memory which means they become ineffective when tumors downregulate their targets. Merck will pay extraordinary sums for inferior technology because Keytruda margins will soon be destroyed. How"
X Link 2025-12-18T17:07Z [---] followers, [----] engagements

"@RIP_GOP1234 BP are bureaucratic organizations. They will move on $NWBO when they are forced. That happens after MHRA approves DCVax for newly diagnosed and recurrent glioblastoma. Management have no reason to sell controlling interest at depressed prices. There will be a bidding war"
X Link 2025-12-18T19:18Z [---] followers, [---] engagements

"@ElvirPons In my opinion management should not get any additional annual cash bonuses until we are net positive on the balance sheet. They have already earned enormous amounts of equity-based compensation. If no buyout additional front line staff are needed to grow $NWBO post approval"
X Link 2025-12-22T19:00Z [---] followers, [----] engagements

"@CscottLawyer @ElvirPons I am not going to spend my Christmas week arguing that the world isn't flat. Enjoy yourself"
X Link 2025-12-22T19:55Z [---] followers, [---] engagements

"Are Chanel Louis Vuitton and all these brands really still luxury If middle-class people have them then how are they luxury They are not since shareholders in these companies want it accessible. What killed Halston is now standard business practice today"
X Link 2025-12-22T21:46Z [---] followers, [---] engagements

"@ButlerCabin1894 How many of these man children have a diver or driver watch with their suit Those are literally a sporting tool not a dress watch which should have a leather band and no bezel What's next expensive hiking boots Men today were never taught how to dress appropriately"
X Link 2025-12-22T22:10Z [---] followers, [--] engagements

"Now it's Frank Sinatra 24/7 for #Christmas2025 https://youtu.be/0iQNrtNu5I8si=kz95OBj0tNJlobx7 https://youtu.be/0iQNrtNu5I8si=kz95OBj0tNJlobx7"
X Link 2025-12-24T00:20Z [---] followers, [---] engagements

"Coming out of the [----] $NWBO ASM as a shareholder since early [----] I was frustrated. Yes we are moving forward with Grade C cleanrooms but relocating them within the Sawston facility and reducing initial scope to manage cash burn and minimize dilution. At first glance that feels slow and not ideal for a commercial launch. Digging deeper this traces back to a disastrous legacy contractor situation. The FACTOR/Flaskworks GMP vendor relationship dates to [----] before current management and before NWBO acquired Flaskworks in [----]. There was no executed SOW. The vendor went off-scope redesigned"
X Link 2025-12-30T15:55Z [---] followers, [----] engagements

"@KaareJohnson @ValentinaForUSA Not long ago they said "No Irish Need Apply." GFYS @ValentinaForUSA"
X Link 2025-12-30T22:54Z [---] followers, [--] engagements

"MAA includes both newly diagnosed and recurrent glioblastoma. Both are statistically significant and clinically proven in $NWBO Landmark PIII Trial. The question will be whether a label expansion out of the gate with post approval monitoring required for added indications such as Grade III Astrocytoma. DCVax has zero toxicity so doing this makes sense for patients and regulators. https://twitter.com/i/web/status/2006419627291619367 https://twitter.com/i/web/status/2006419627291619367"
X Link 2025-12-31T17:38Z [---] followers, [----] engagements

"@smith348572 Remember 5/10/2022. No halts on OTC. It is not an exchange but a decentralized quotation network. FINRA only halts OTC for overseas corporate actions not volatility. No Circuit Breaker for $NWBO"
X Link 2026-01-03T02:35Z [---] followers, [---] engagements

"In terms of relationship to the Mississippi River itself thus ability to see / interact with it as a pedestrian: New Orleans Memphis Minneapolis St Louis If St Louis had removed I-70 through its downtown then it would be ranked higher but it is still very much disconnected from the river given access blocked by industrial use. https://twitter.com/i/web/status/2010140249314521358 https://twitter.com/i/web/status/2010140249314521358"
X Link 2026-01-11T00:02Z [---] followers, [---] engagements

"@UrbanCourtyard So the thesis is basically: take Pruitt-Igoe towers make them a bit shorter slap mansard roofs on top and arrange them into a square Instead of "towers in the park" it's now "towers around a park." Not innovation rather it's modernist failure with better branding"
X Link 2026-01-12T00:53Z [---] followers, [--] engagements

"Your whole idea collapses in real life. That "courtyard park" will not be a park rather it wil be: - the dog bathroom - the kid noise zone - an echo chamber of amplified sound - panopticon Wrong scale. Zero privacy. Constant surveillance. It's just top-down modernist topology with Second Empire stylistic vibes imposed on cities. https://twitter.com/i/web/status/2010518979412938818 https://twitter.com/i/web/status/2010518979412938818"
X Link 2026-01-12T01:07Z [---] followers, [--] engagements

"Yes condos are ideal for foreign real estate speculation. Canadian real estate market has been a disaster for over a decade due to this reason along with growth boundaries in cities like Toronto and Vancouver. Calgary does not have land locked up like in Ontario or British Columbia but they still operate under the same market incentives which steer development into condos over single family detached homes. https://twitter.com/i/web/status/2010915046180769994 https://twitter.com/i/web/status/2010915046180769994"
X Link 2026-01-13T03:21Z [---] followers, [---] engagements

"So why is Chicago still treating the lakefront like a sacred museum Develop the lakefront. Build mixed-income high-rises with 20-30% affordable units parks transit and retail. Expand the tax base. Create real family housing in the most desirable location. Right now the only people who truly enjoy the lakefront daily are the wealthy households who already live next to it. The lakefront is an asset. If you want a middle class electorate then the solution is obvious. https://twitter.com/i/web/status/2011128813728538978 https://twitter.com/i/web/status/2011128813728538978"
X Link 2026-01-13T17:30Z [---] followers, [---] engagements

"@JohnSmith410846 @chisportsfan442 @jacobinfante24 City of Chicago cannot sell the land. Supreme Court prevents any development on the lakefront. Only Illinois legislature can override. This is why Soldier's Field will never be a good location for NFL as it's impossible to build anything around it. https://www.illinoiscourts.gov/News/681/Illinois-Supreme-Court-History-Montgomery-Ward-and-the-Chicago-Lake-Front/news-detail/ https://www.illinoiscourts.gov/News/681/Illinois-Supreme-Court-History-Montgomery-Ward-and-the-Chicago-Lake-Front/news-detail/"
X Link 2026-01-16T21:46Z [---] followers, [--] engagements

"@AJManaseer Yes they should also override the Supreme Court and allow a new stadium on the lakefront with residential and commercial real estate. https://www.illinoiscourts.gov/News/681/Illinois-Supreme-Court-History-Montgomery-Ward-and-the-Chicago-Lake-Front/news-detail/ https://www.illinoiscourts.gov/News/681/Illinois-Supreme-Court-History-Montgomery-Ward-and-the-Chicago-Lake-Front/news-detail/"
X Link 2026-01-16T21:51Z [---] followers, [---] engagements

"@andrewcaravello @clausknielsen London does 4B/day. US equities do $600B/day. 100x difference. If $NWBO uplists it's US markets as that's where the liquidity and biotech capital actually exist"
X Link 2026-01-18T17:55Z [---] followers, [---] engagements

"@clausknielsen @andrewcaravello Most do not understand Europe fragmented and illiquid compared to US markets. Less depth worse price discovery. London uplist would be downgrade as US biotechs go to NASDAQ. In fact $NWBO has been on LSE as ADR since [----] and nobody knew because it never clears a trade πŸ€ͺ"
X Link 2026-01-18T18:10Z [---] followers, [---] engagements

"@Scaramucci Patron Saint of Long Haul Truckers Who Drink Ptrus Flexing $50k+ of trophy wine while heading to the "inequality summit." πŸ˜±πŸ˜†πŸ₯‚"
X Link 2026-01-18T18:59Z [---] followers, [---] engagements

"@2024dion You can blame Urban Renewal and White Flight (Mapping Decline by Colin Gordon) but St Louis' elites left town while local officials fought zero sum game. Peirce Reports in Post Dispatch warned of the outcome we see today. https://www.nealpeircefoundation.org/peirce-reports-archive/ https://www.goodreads.com/book/show/3045503-mapping-decline https://www.nealpeircefoundation.org/peirce-reports-archive/ https://www.goodreads.com/book/show/3045503-mapping-decline"
X Link 2026-01-18T19:08Z [---] followers, [---] engagements

"LSE and Stuttgart behave like an ADR: a thin foreign wrapper that tracks the US common and does not create real liquidity for the actual domestic listing where the company actually raises capital Calling that an "uplist" path for $NWBO is still nonsense"
X Link 2026-01-18T19:14Z [---] followers, [---] engagements

"@JacobPlieth @singhlosophy @Sanctuary_Bio You mean the company with GMP approval $NWBO vs the one which got CRL $IBRX because it couldn't manufacture a basic cytokine Must be great to not create anything then spend your time attacking a company published in JAMA and Nature"
X Link 2026-01-19T21:43Z [---] followers, [----] engagements

"@UrbanCourtyard @fhjckaka Here comes an urban planner to save St Louis"
X Link 2026-01-20T03:42Z [---] followers, [--] engagements

"@BulwarkOnline That's Davos"
X Link 2026-01-20T16:19Z [---] followers, [---] engagements

"@mnolangray Detroit has Dan Gilbert. St Louis has Paul McKee"
X Link 2026-01-20T17:12Z [---] followers, [----] engagements

"@adonispara With a negroni and Nat Sherman"
X Link 2026-01-20T17:53Z [---] followers, [---] engagements

"@thealepalombo Also a flat in Monti neighborhood of Roma"
X Link 2026-01-20T20:31Z [---] followers, [--] engagements

"This is a tired talking point. Louisiana's insurance problem is not billboard attorneys. It is poverty + uninsured drivers + crash frequency + drunk driving + theft + and catastrophic flooding/storm losses. Those factors drive claim frequency and severity and that is what insurers price. Attorneys do not cause wrecks or floods. They exist because people get hurt and need recourse. And a lot of people get hurt because driving in New Orleans is extremely dangerous. If you remove the ability to sue then you are not fixing the risk rather you are just protecting insurers."
X Link 2026-01-21T17:50Z [---] followers, [--] engagements

"@GavinNewsom Repeal the Patriot Act abolish @DHSgov @TSA @ICEgov. America was far safer before [----]. It was certainly a more civilized country"
X Link 2026-01-25T02:39Z [---] followers, [--] engagements

"@marcorasi1960 AMAZING One of my favorite places in New Orleans"
X Link 2026-01-27T01:37Z [---] followers, [--] engagements

"Funny now selective outrage works. Crime was rampant for years under Bobby Jindal while he hollowed out healthcare cut higher ed to the bone and left the state broke and bleeding people. This did not happen in a vacuum. Post-Katrina was Louisiana's chance to rebuild and Bobby Jindal squandered it by gutting healthcare and education while papering over deficits. You are looking at long-term institutional damage not a sudden crime wave that started this year. You do not get to memory-hole a decade of policy failure and pretend this is some sudden mystery. If you actually care about public"
X Link 2026-01-27T17:06Z [---] followers, [--] engagements

"@GoneGoodguy @d_stock07734 @maxstradamus21 Merck's acquisition history combined with reported DCVax combination studies using pembrolizumab suggests $NWBO DCVax is already being evaluated as a potential foundational antigen-presentation platform. Regulatory validation would materially elevate its strategic relevance"
X Link 2026-01-29T16:35Z [---] followers, [---] engagements

"My M340i will do [---] down the highway one-handed AC blasting dead stable like it's nothing and still have torque to keep going. That Boss shit is a museum piece that's fighting for its life at speeds (120) modern cars sleepwalk through. Absolute waste of money pure boomer cosplay unstable zero real performance"
X Link 2026-01-30T00:10Z [---] followers, [--] engagements

"Yes they are making connections and that's the problem. Hub-and-spoke is fragile carbon-intensive delay-prone systems design from the 1970s. One storm one crew issue one hub melts and half the country eats it. LAX is the purest example of US transportation failure: an irredeemable airport impossible to fix impossible to replace propped up as a single point of failure for passengers and freight. We concentrated half the West Coast's mobility and logistics into one carbon-spewing choke point and then act surprised when the system collapses. In addition small cities cant be served by rail is BS."
X Link 2026-01-30T18:23Z [---] followers, [---] engagements

"@jtsla4 Around 40% of silver demand comes from industry (electronics solar panels etc) so it's actually a high beta asset as it moves with the market. The market for silver is illiquid. In a recession you should not expect silver to be a safe haven"
X Link 2026-01-30T22:10Z [---] followers, [----] engagements

"@jtsla4 Commodities are inputs. Inputs are cyclical. Period. If something is primarily used to make other things its demand is tied to production capex and consumption. When the economy slows those fall. That's not ideology that's accounting. Never go full commodities. #OOTT"
X Link 2026-01-30T22:13Z [---] followers, [---] engagements

"@patrickwalsh14 @ATLnsider @glen_bwrhr42 Novartis shareholders disagree. $NWBO has potential for approval next week. https://www.novartis.com/uk-en/news/media-releases/novartis-kisqali-ribociclib-receives-mhra-authorisation-adjuvant-treatment-hrher2-early-breast-cancer-high-risk-recurrence-broad-population-patients https://www.novartis.com/uk-en/news/media-releases/novartis-kisqali-ribociclib-receives-mhra-authorisation-adjuvant-treatment-hrher2-early-breast-cancer-high-risk-recurrence-broad-population-patients"
X Link 2026-01-30T22:21Z [---] followers, [---] engagements

"@L_33_H @BMW @BMWGroup F30 better especially B58 vs N55"
X Link 2026-02-03T17:49Z [---] followers, [--] engagements

"@thealepalombo In the next few years I plan on buying a flat in Monti and villa outside Florence. The Italian people are the most welcoming in Europe"
X Link 2026-02-03T18:04Z [---] followers, [----] engagements

"Complaining about property taxes in a state with zero income tax and zero capital gains tax is peak small-picture thinking. If you have any equity at all you are coming out millions ahead in Texas. The math is not hard: stop whining about the cost of the concrete and start appreciating that the state stays out of your paycheck and your portfolio. If you want to be taxed on your labor and your investments then move to New Jersey New York California or Illinois. https://twitter.com/i/web/status/2018931303178002628 https://twitter.com/i/web/status/2018931303178002628"
X Link 2026-02-04T06:15Z [---] followers, [---] engagements

"Dr. Balakumaran's extensive background includes transformative roles such as the former Chief Medical Officer at Allogene and the Product Development Lead at Merck. At Merck he was recognized as a Merck Distinguished Scientist and played a pivotal role in the development of Keytruda a broad-spectrum cancer drug. Trained in clinical and laboratory research at the National Institutes of Health (NIH) he has built a robust foundation in medical science. https://www.cancerchecklabs.com/about-us/meet-the-team https://www.cancerchecklabs.com/about-us/meet-the-team"
X Link 2026-02-04T22:56Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

creator/x::DCVaxDefender
/creator/x::DCVaxDefender